These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26719290)

  • 1. Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.
    Powers BE; Velazquez R; Kelley CM; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
    Brain Struct Funct; 2016 Dec; 221(9):4337-4352. PubMed ID: 26719290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspring.
    Powers BE; Kelley CM; Velazquez R; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
    Neuroscience; 2017 Jan; 340():501-514. PubMed ID: 27840230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.
    Ash JA; Velazquez R; Kelley CM; Powers BE; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2014 Oct; 70():32-42. PubMed ID: 24932939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease.
    Alldred MJ; Penikalapati SC; Lee SH; Heguy A; Roussos P; Ginsberg SD
    Mol Neurobiol; 2021 Oct; 58(10):5141-5162. PubMed ID: 34263425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
    Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation.
    Alldred MJ; Pidikiti H; Heguy A; Roussos P; Ginsberg SD
    FASEB J; 2023 Jun; 37(6):e22944. PubMed ID: 37191946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM; Ginsberg SD; Alldred MJ; Strupp BJ; Mufson EJ
    Dev Neurobiol; 2019 Jul; 79(7):664-683. PubMed ID: 31120189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
    Brain Pathol; 2014 Jan; 24(1):33-44. PubMed ID: 23802663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.
    Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
    J Comp Neurol; 2014 Apr; 522(6):1390-410. PubMed ID: 24178831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ
    Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.
    Moon J; Chen M; Gandhy SU; Strawderman M; Levitsky DA; Maclean KN; Strupp BJ
    Behav Neurosci; 2010 Jun; 124(3):346-61. PubMed ID: 20528079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.
    Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
    Hippocampus; 2018 Apr; 28(4):251-268. PubMed ID: 29394516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
    Chen Y; Dyakin VV; Branch CA; Ardekani B; Yang D; Guilfoyle DN; Peterson J; Peterhoff C; Ginsberg SD; Cataldo AM; Nixon RA
    Neurobiol Aging; 2009 Sep; 30(9):1453-65. PubMed ID: 18180075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.
    Geula C; Dunlop SR; Ayala I; Kawles AS; Flanagan ME; Gefen T; Mesulam MM
    J Neurochem; 2021 Sep; 158(6):1394-1411. PubMed ID: 34272732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age exacerbates abnormal protein expression in a mouse model of Down syndrome.
    Ahmed MM; Block A; Tong S; Davisson MT; Gardiner KJ
    Neurobiol Aging; 2017 Sep; 57():120-132. PubMed ID: 28641136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
    Hyde LA; Crnic LS
    Behav Neurosci; 2001 Dec; 115(6):1239-46. PubMed ID: 11770055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.